Giovanni Marsicano Selected Research

Giovanni Marsicano Research Topics

Disease

12	Obesity 04/2024 - 02/2006
7	Body Weight (Weight, Body) 01/2021 - 08/2008
3	Neoplasms (Cancer) 04/2023 - 01/2008
3	Inflammation (Inflammations) 01/2023 - 04/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 12/2012
3	Seizures (Absence Seizure) 06/2013 - 10/2003
2	Cognitive Dysfunction 01/2022 - 01/2017
2	Memory Disorders (Memory Loss) 01/2022 - 07/2007
2	Autism Spectrum Disorder 01/2022 - 01/2021
2	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2012
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 06/2009
2	Insulin Resistance 01/2016 - 09/2008
2	Multiple Sclerosis 01/2014 - 04/2007
2	Hypothermia 01/2014 - 06/2013
2	Disease Progression 01/2011 - 06/2009
2	Pain (Aches) 08/2009 - 07/2007
1	Neoplasm Metastasis (Metastasis) 04/2023
1	Brain Neoplasms (Brain Tumor) 04/2023
1	Melanoma (Melanoma, Malignant) 04/2023
1	Glioblastoma (Glioblastoma Multiforme) 12/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 12/2021
1	Hyperphagia (Overeating) 10/2021
1	Neurodevelopmental Disorders 01/2021
1	Motor Disorders 01/2021
1	Catalepsy 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Tremor (Tremors) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Essential Tremor (Essential Tremors) 01/2021
1	Ataxia (Dyssynergia) 12/2020
1	Amnesia (Dissociative Amnesia) 11/2016
1	Glucose Intolerance 01/2016
1	Ischemic Stroke 02/2014
1	Infarction (Infarctions) 09/2013
1	Brain Ischemia (Cerebral Ischemia) 09/2013
1	Metabolic Diseases (Metabolic Disease) 09/2012
1	Huntington Disease (Huntington's Disease) 01/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2009
1	Neuroinflammatory Diseases 06/2009
1	Fatty Liver 09/2008
1	Hyperglycemia 09/2008
1	Alcoholic Fatty Liver 03/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2008
1	Aberrant Crypt Foci 01/2008
1	Major Depressive Disorder (Major Depressive Disorders) 01/2008

Drug/Important Bio-Agent (IBA)

22	EndocannabinoidsIBA 01/2023 - 04/2004
18	CannabinoidsIBA 04/2023 - 04/2004
11	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2023 - 10/2006
6	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 04/2007
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2024 - 10/2019
3	Insulin (Novolin)FDA Link 01/2021 - 09/2008
3	RimonabantIBA 01/2016 - 04/2004
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 10/2019
2	Dronabinol (THC)FDA LinkGeneric 12/2020 - 06/2013
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 10/2006
2	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 09/2008
2	Cannabinoid Receptor AgonistsIBA 06/2009 - 04/2004
2	LipidsIBA 09/2008 - 08/2007
2	Kainic Acid (Kainate)IBA 08/2006 - 10/2003
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2023
1	Glutamic Acid (Glutamate)FDA Link 04/2023
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2023
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 04/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2023
1	CalciumIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2022
1	Lactate DehydrogenasesIBA 12/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2022
1	stiripentolIBA 12/2022
1	Protein Isoforms (Isoforms)IBA 12/2022
1	NeurosteroidsIBA 01/2022
1	PregnenoloneIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	DisaccharidesIBA 12/2020
1	TrehaloseIBA 12/2020
1	temsirolimus FDA Link 12/2020
1	JZL 184IBA 01/2017
1	Nicotine FDA Link 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Glycogen Synthase (Synthase I)IBA 02/2014
1	Peptides (Polypeptides)IBA 09/2013
1	LipoxinsIBA 12/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	N-acylethanolaminesIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2009
1	LeptinIBA 09/2008
1	arachidonoylserotoninIBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Cranial Irradiation 12/2022
1	Spinal Injections 01/2021
1	Chemical Sympathectomy 02/2015
1	Electroacupuncture 02/2014
1	Drug Therapy (Chemotherapy) 06/2009